Mezzion Pharma Co.,Ltd.

140410.KQ

140410.KQMezzion Pharma Co.,Ltd. KR flag

KOSDAQ

32,300.00

KRW

-150.00

(-0.46%)

967.67BMarket Cap

May 13Next Earn

Upgrade to Unlock Non-US CompaniesTo view real-time data and analysis of companies outside of the United States, upgrade your account to our premium subscription.

Upgrade

ISIN

KR7140410002

Return %

Stock

S&P500

-27.09

10.92

32.74

26.22

-12.70

120.31

Use logarithmic scale

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	TTM
Revenue per Share	279.34	378.33	201.37	212.49	659.85	395.84	250.23	766.14	689.8	1,100.84	998.74	1,149.55	1,123.96	478.49
Basic EPS, GAAP	176.67	105	-38	-112.33	186.67	-587.33	-666.67	-757.67	-895	-531.67	-509.7	-1,358	-451	-483.46
Free Cash Flow per Basic Share	-101.45	130.84	-162.99	-207.96	53.41	-282.53	-683.71	-894.93	-846	-589.48	-796.4	-517.63	-810.75	-869.95
Dividend per Share	- -	- -	8.34	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Book Value per Share	1,248.71	1,133.11	1,122.61	957.4	1,146.55	632.55	-42.72	-795.17	-1,655.81	-2,180.6	-2,635.63	-3,654.53	-3,859.3	- -
Tangible Book Value per Share	1,499.22	2,741.06	2,794.53	2,761.44	2,652.65	2,374.84	2,308.6	2,235.07	1,586.29	1,867.2	1,821.64	921.11	1,718.52	1,827.47
Basic Weighted Avg Shares	18	23	22	23	23	22	22	25	26	26	27	27	28	29
Sales/Revenue/Turnover	5,067	8,592	4,402	4,857	14,926	8,751	5,586	19,088	17,920	28,634	26,654	30,726	31,721	14,077
Operating Margin (%)	55.82	19.56	-56.17	-101.22	-18.31	-82.5	-301.59	-114.87	-136.62	-26.3	-63.02	-75.93	-45.68	-81.09
Depreciation Expense	40	49	48	151	343	415	62	228	1,332	1,432	1,586	1,658	1,546	894
Net Income, GAAP	3,204	2,385	-831	-2,568	4,223	-12,985	-14,882	-18,876	-23,251	-13,829	-13,603	-36,298	-12,728	-14,223
Effective Tax Rate (%)	21.69	20.49	- -	- -	18.19	- -	- -	- -	- -	- -	- -	- -	- -	63.96
Profit Margin (%)	63.24	27.75	-18.87	-52.86	28.29	-148.38	-266.42	-98.89	-129.75	-48.3	-51.03	-118.13	-40.13	-101.04
Working Capital	16,831	56,626	58,103	62,804	83,609	77,713	50,007	52,278	38,339	45,155	45,678	19,817	44,628	30,783
LT Debt	- -	- -	- -	- -	25,236	26,255	- -	- -	2,420	3,104	2,338	1,625	- -	- -
Total Equity	28,170	63,336	62,177	66,151	62,537	52,809	53,169	57,319	42,830	56,810	62,793	26,240	61,444	53,763
Return on Invested Capital (%)	7.99	2.92	- -	- -	-2.91	- -	- -	- -	- -	- -	- -	- -	- -	- -
Return on Capital (%)	15.27	9.86	- -	- -	14.78	- -	- -	- -	- -	- -	- -	- -	- -	5.77
Return on Common Equity (%)	15.27	9.86	-3.3	-11.06	17.66	-65.05	- -	- -	- -	- -	- -	- -	- -	- -

Capital Structure

•

in mil. unless spec.

Working Capital

•

in mil. unless spec.

Growth Rates

FRC

•

in mil. unless spec.

(avg. rate of change)	10 years	5 years	1 year
Sales/Revenue/Turnover	44.71%	13.06%	3.24%
Net Income, GAAP	-33.85%	16.59%	-64.93%
Free Cash Flow	-48.11%	7.49%	65.38%
Total Cash Common Dividend	- -	- -	- -
Total Equity	8.77%	18.77%	134.16%

Growth Rates

•

in mil. unless spec.

Quarterly Revenue

•

in mil. unless spec.

Quarterly Earnings Per Share

•

in mil. unless spec.

Quarterly Dividends Per Share

•

in mil. unless spec.

Company Description

Address
IPO Date: Jan 20, 2012
Similar Companies: ForceField Energy Inc. (FNRG)
CHATHA Foods Limited (CHATHA.BO)
Investeringsforeningen C Worldwide Indien Kl (CWIIA.CO)
Investeringsforeningen Advice Capital - Investeringsforeningen Advice Capital - Afdeling Advice Capi (ACIBB.CO)
Crucible Acquisition Corporatio (CRU-WT)
Adevinta ASA (ADEO.OL)
Business

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	TTM
Revenue per Share	279.34	378.33	201.37	212.49	659.85	395.84	250.23	766.14	689.8	1,100.84	998.74	1,149.55	1,123.96	478.49
Basic EPS, GAAP	176.67	105	-38	-112.33	186.67	-587.33	-666.67	-757.67	-895	-531.67	-509.7	-1,358	-451	-483.46
Free Cash Flow per Basic Share	-101.45	130.84	-162.99	-207.96	53.41	-282.53	-683.71	-894.93	-846	-589.48	-796.4	-517.63	-810.75	-869.95
Dividend per Share	- -	- -	8.34	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Book Value per Share	1,248.71	1,133.11	1,122.61	957.4	1,146.55	632.55	-42.72	-795.17	-1,655.81	-2,180.6	-2,635.63	-3,654.53	-3,859.3	- -
Tangible Book Value per Share	1,499.22	2,741.06	2,794.53	2,761.44	2,652.65	2,374.84	2,308.6	2,235.07	1,586.29	1,867.2	1,821.64	921.11	1,718.52	1,827.47
Basic Weighted Avg Shares	18	23	22	23	23	22	22	25	26	26	27	27	28	29
Sales/Revenue/Turnover	5,067	8,592	4,402	4,857	14,926	8,751	5,586	19,088	17,920	28,634	26,654	30,726	31,721	14,077
Operating Margin (%)	55.82	19.56	-56.17	-101.22	-18.31	-82.5	-301.59	-114.87	-136.62	-26.3	-63.02	-75.93	-45.68	-81.09
Depreciation Expense	40	49	48	151	343	415	62	228	1,332	1,432	1,586	1,658	1,546	894
Net Income, GAAP	3,204	2,385	-831	-2,568	4,223	-12,985	-14,882	-18,876	-23,251	-13,829	-13,603	-36,298	-12,728	-14,223
Effective Tax Rate (%)	21.69	20.49	- -	- -	18.19	- -	- -	- -	- -	- -	- -	- -	- -	63.96
Profit Margin (%)	63.24	27.75	-18.87	-52.86	28.29	-148.38	-266.42	-98.89	-129.75	-48.3	-51.03	-118.13	-40.13	-101.04
Working Capital	16,831	56,626	58,103	62,804	83,609	77,713	50,007	52,278	38,339	45,155	45,678	19,817	44,628	30,783
LT Debt	- -	- -	- -	- -	25,236	26,255	- -	- -	2,420	3,104	2,338	1,625	- -	- -
Total Equity	28,170	63,336	62,177	66,151	62,537	52,809	53,169	57,319	42,830	56,810	62,793	26,240	61,444	53,763
Return on Invested Capital (%)	7.99	2.92	- -	- -	-2.91	- -	- -	- -	- -	- -	- -	- -	- -	- -
Return on Capital (%)	15.27	9.86	- -	- -	14.78	- -	- -	- -	- -	- -	- -	- -	- -	5.77
Return on Common Equity (%)	15.27	9.86	-3.3	-11.06	17.66	-65.05	- -	- -	- -	- -	- -	- -	- -	- -

	Mar'24	Jun'24	Sep'24
Total Current Assets	67,812	56,907	50,330
Accounts Receivable, Net	1,101	1,131	- -
Cash, Cash Equivalents & STI	53,635	41,122	- -
Inventories	5,744	5,521	- -
Total Current Liabilities	28,962	21,491	19,547
Payables & Accruals	- -	- -	- -
ST Debt	1,454	732	- -
Deferred Revenue	- -	- -	- -

	Mar'24	Jun'24	Sep'24
ST Debt	1,454	732	- -
LT Borrowings	- -	- -	- -
LT Finance Leases	- -	- -	- -
Preferred Equity and Hybrid Capital	- -	- -	- -
Shares Outstanding	30	30	30
Market Capitalization	1,121,293	1,093,506	797,266

Year	Q1	Q2	Q3	Q4	FY
2022	6,682	8,259	8,015	7,769	30,726
2023	7,788	8,113	8,430	7,390	31,721
2024	2,158	2,269	2,261	- -	- -

Year	Q1	Q2	Q3	Q4	FY
2022	-52.33	-604	81	- -	-1,358
2023	-93	-107	-33.12	- -	-451
2024	- -	-55	- -	- -	- -

Mezzion Pharma Co.,Ltd.

Growth Rates

(avg. rate of change)

Company Description

Growth Rates

(avg. rate of change)

Working Capital

Capital Structure

Quarterly Revenue

Year

Quarterly Earnings Per Share

Year

Quarterly Dividends Per Share

Year